Intellectual Property (IP) Strategies To Consider for Life Sciences Start-Ups

Intellectual property (IP) is one of the most valuable assets a life sciences innovator or start-up has. While these companies are often built on the foundations of successful pre-clinical studies, they face a substantial amount of time between obtaining regulatory approvals and introducing a drug onto the market.

Additionally, hefty investment from external sources is required to maintain their ideas and support eventual development, while also protecting against competitor infringement. However, attracting the necessary capital can be tricky without first obtaining the appropriate protections for your IP.

Here are four key considerations for life sciences start-ups when filing for IP protections.